Table: begin end state 1 8 cytoplasmic 9 26 transmembrane 27 32 non-cytoplasmic 33 54 transmembrane 55 61 cytoplasmic 62 80 transmembrane 81 107 non-cytoplasmic 108 136 transmembrane 137 143 cytoplasmic 144 162 transmembrane 163 181 non-cytoplasmic 182 206 transmembrane 207 229 cytoplasmic 230 249 transmembrane 250 268 non-cytoplasmic 269 290 transmembrane 291 301 cytoplasmic 302 323 transmembrane 324 334 non-cytoplasmic 335 358 transmembrane 359 364 cytoplasmic 365 384 transmembrane 385 389 non-cytoplasmic 390 413 transmembrane 414 424 cytoplasmic 425 449 transmembrane 450 450 non-cytoplasmic
Input: >PfGW456L13_1927 FitnessBrowser__pseudo13_GW456_L13:PfGW456L13_1927 MFGMSHETFLLLDAVVTVIGLIVLITKFKLHPFLALIIAAAFLGLTSGMPIGTIIKAFQD GFGGVLGFVGIILALGTMLGKMMAESGGADQIAQTLIRAFGKDKVQWAMMFAAFLVGIPL FFEIGFVLLIPLVFIVARRTGVSIIKIGIPLLAGLSAVHGLVPPHPGPLLAIGVFGADIG KTILYGLIVALPTAIIAGPIFGTFIAKHIPGHPNQELVDQLSRETDSAELPSFGITLVTV LLPVFLMLLKTFADVVLPDGNIFRAFMDLIGHPISALLLALLLSLYTFGYKQGIGSSQMM KWLDASLAPTAAIILIIGAGGGFKQMLVTSGVGDVIGHMAVNAQISPILLAWLVAAVIRI ATGSATVATITGAGIVVPVVGMIPGVNRELLVLATGAGSLILSHVNDAGFWLVKQYFNMT VAETFKTWTAMETILSVVGLGFILLLSLFV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server